Target Name: OR2M4
NCBI ID: G26245
Review Report on OR2M4 Target / Biomarker Content of Review Report on OR2M4 Target / Biomarker
OR2M4
Other Name(s): Olfactory receptor OR1-55 | HSHTPCRX18 | Novel 7 transmembrane receptor (rhodopsin family) protein | olfactory receptor TPCR100 | TPCR100 | olfactory receptor OR1-55 | Olfactory receptor 2M4 | olfactory receptor family 2 subfamily M member 4 | OTTHUMP00000038273 | OR2M4_HUMAN | Olfactory receptor family 2 subfamily M member 4 | OR1-55 | HTPCRX18 | OST710 | Olfactory receptor TPCR100 | Olfactory receptor, family 2, subfamily M, member 4 | novel 7 transmembrane receptor (rhodopsin family) protein

Olfactory Receptor OR1-55: A Protein Implicated in Smell and Taste

Olfactory receptor OR1-55 is a protein that plays a crucial role in the sense of smell and taste. It is one of the five olfactory receptors found on the human tongue, and it is responsible for sensing smell and taste in the air.

OR1-55 is a G protein-coupled receptor (GPCR), which means it is a transmembrane protein that is involved in cell-cell signaling. GPCR is a family of proteins that are found in many different cell types in the body, including sensory neurons and brain cells.

OR1-55 is expressed in the olfactory epithelium, which is the lining of the olfactory organs (such as the nose and the sense of smell). It is thought to play a role in the perception of pheromones, which are chemical molecules that are produced by other individuals.

OR1-55 has also been shown to be involved in the regulation of pain and inflammation. Studies have shown that when OR1-55 is activated, it can cause the olfactory organ to release a neurotransmitter called nitric oxide (NO), which can help to reduce pain and inflammation.

OR1-55 is also a potential drug target in the sense of smell. Several studies have shown that inhibiting OR1-55 can cause a decrease in the sense of smell, which could be useful for treating disorders of the sense of smell, such as smell Anosmia (olfactory agnosia means that although the patient can sense the surrounding environment, he is unable to recognize specific smells and tastes) and hyperosmia.

OR1-55 has also been shown to be involved in the regulation of the immune system. Studies have shown that OR1-55 can modulate the activity of T cells, which are a type of immune cell that help to protect the body against infection.

In addition to its potential drug-targeting potential, OR1-55 is also a valuable biomarker for several diseases, including cancer. Studies have shown that OR1-55 can be expressed in the cells of cancer cells, and that inhibiting OR1-55 can cause cancer cells to undergo apoptosis (cell apoptosis), which is a natural and programmed cell death).

OR1-55 is also a potential biomarker for several other diseases, including neurological and psychiatric disorders. Studies have shown that OR1-55 is involved in the regulation of neural signaling in the brain, and that abnormal levels of OR1-55 in the brain can contribute to the development of these disorders.

In conclusion, OR1-55 is a protein that plays a crucial role in the sense of smell and taste. It is a GPCR that is involved in cell-cell signaling and has been shown to be involved in the regulation of pain and inflammation. In In addition to its potential drug-targeting potential, OR1-55 is also a valuable biomarker for several diseases, including cancer and neurological and psychiatric disorders. Further research is needed to fully understand the role of OR1-55 in the sense of smell and to develop effective treatments for its associated disorders.

Protein Name: Olfactory Receptor Family 2 Subfamily M Member 4

Functions: Odorant receptor

The "OR2M4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR2M4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR2M5 | OR2M7 | OR2Q1P | OR2S2 | OR2T1 | OR2T10 | OR2T11 | OR2T12 | OR2T2 | OR2T27 | OR2T29 | OR2T3 | OR2T33 | OR2T34 | OR2T35 | OR2T4 | OR2T5 | OR2T6 | OR2T7 | OR2T8 | OR2U1P | OR2V1 | OR2V2 | OR2W1 | OR2W1-AS1 | OR2W3 | OR2W5P | OR2W6P | OR2Y1 | OR2Z1 | OR3A1 | OR3A2 | OR3A3 | OR3A4P | OR4A14P | OR4A15 | OR4A16 | OR4A17P | OR4A21P | OR4A47 | OR4A5 | OR4B1 | OR4C11 | OR4C12 | OR4C13 | OR4C15 | OR4C16 | OR4C1P | OR4C3 | OR4C45 | OR4C46 | OR4C5 | OR4C50P | OR4C6 | OR4D1 | OR4D10 | OR4D11 | OR4D2 | OR4D5 | OR4D6 | OR4D9 | OR4E2 | OR4F13P | OR4F15 | OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2